AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimaday 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimaday 2mg/500mg Tablet ER

Diabeticare Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication, prescribed for adult-onset type 2 diabetes, effectively manages blood glucose. Diabeticare Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled glucose levels, is vital. Discontinuation without medical counsel risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb impairment. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial for prevention. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart conditions should inform their doctor prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Glimaday 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimaday 2mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 2mg/500mg Glimaday Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glimaday 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimaday 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Glimaday 2mg/500mg Extended-Release tablets should be administered with a meal.

How Glimaday 2mg/500mg Tablet ER works:

Glimepiride and Metformin 2mg/500mg Extended-Release tablets (Glimaday) offer dual-action diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, works multi-prongedly: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Glimaday 2mg/500mg extended-release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimada tablets (2mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimaday tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimaday 2mg/500mg Extended-Release tablets, as dose modification may be necessary. Consult your physician for guidance. Glimaday 2mg/500mg ER tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimaday 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dose; however, Glimaday 2mg/500mg Extended-Release tablets are contraindicated in individuals with severe liver disease.

What if you forget to take Glimaday 2mg/500mg Tablet ER :

Should you forget a Glimaday 2mg/500mg Extended-Release tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimaday 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimaday 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimaday 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimaday 2mg/500mg Tablet ER and seek immediate medical attention.
Glimaday 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimaday 2mg/500mg Extended-Release Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimaday 2mg/500mg Extended-Release tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimaday 2mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimaday 2mg/500mg ER tablets with alcohol is unsafe. Alcohol can further lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Glimaday 2mg/500mg Tablet...
88
MRP 102
13% off